Centrus Energy reported third quarter 2026 revenue of $55.5 million, down 26% from $74.9 million a year earlier, and a gross loss of $10.6 million. GAAP net income rose to $31.6 million, but that result includes a $46.4 million gain from revaluing warrant liabilities, and the company reported an adjusted net loss of $9.4 million. The filing also updated full-year 2026 guidance and said the DOE does not currently intend to exercise further options under the HALEU Operation Contract.
Q3 2026 revenue was $55.5 million versus $74.9 million in Q3 2025; gross loss widened to $10.6 million from $4.3 million.
GAAP net income was $31.6 million ($1.41 diluted EPS), including a $46.4 million warrant fair value gain; adjusted net loss was $9.4 million versus adjusted net income of $5.2 million a year earlier.
Full-year 2026 revenue guidance is $450 million to $500 million, and total capital deployment is expected at $350 million to $500 million.
The current DOE budget proposal for fiscal 2027 does not fund HALEU Operation Contract cascade operations, which represents about $0.8 billion of Technical Solutions backlog.
Centrus Energy said its Oak Ridge, Tennessee plant has completed and shipped the first new centrifuge for its multibillion-dollar uranium enrichment expansion, with components to be assembled in Ohio. The company said this and a complete domestic supply chain were achieved ahead of its previously announced year-end target, but the filing contains no financial results or updated guidance.
First new centrifuge completed and shipped from Oak Ridge on October 29, 2026, ahead of the previously announced year-end target.
Centrus said it completed its acquisition of Westerman Holdings, a supplier of centrifuge casings, earlier in October 2026.
The company announced a $560 million investment in January 2026 to expand its Oak Ridge plant, and first new capacity in Ohio is expected to come online in 2029.
Centrus Energy Corp. bought 100% of Westerman Holdings, LLC on October 16, 2026, from the trustee of the Westerman Employee Stock Ownership Trust for approximately $116.0 million. Westerman already makes centrifuge casings and other major components for Centrus, and the company says the deal secures that supply chain and diversifies its revenue into non-nuclear markets. Centrus expects the acquisition to be accretive to adjusted earnings per share in the first year after closing, and it issued $21.0 million of Class A common stock as part of the price.
Purchase price of approximately $116.0 million, including $95.0 million in cash and $21.0 million in Class A common stock, closed October 16, 2026.
About $31.5 million went to Westerman subordinated noteholders and $12.7 million to its term loan lender, paid out of the purchase price.
Centrus expects the deal to be accretive to adjusted EPS in the first year after closing; the price is subject to a customary working capital adjustment.
Westerman has about 400 employees and four facilities in Ohio, Oklahoma and Wyoming, and Centrus plans to file a shelf registration for the stock issued.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.